Analyst Research Report Snapshot

Title:

Spark Capital: PGCIL - 3QFY13 Results Review

Price:

$58.00

Provider:

Spark Capital Advisors(India) Private Limited

Date:

20 Feb 2013

Pages:

6

Type:

AcrobatPDF

Companies referenced:

PGRD.NS

Available for Immediate Download
Summary:

Operationally in-line quarter; maintain Add on strong demonstration of capex growth PGCIL reported a good quarter with net-profits of Rs. 11.29bn up 44% yoy, primarily due to a robust growth in the transmission income which grew by 41% yoy. Adjusting for the exchange rate variation of Rs. 225mn the net profits stand at Rs. 11.10bn for the quarter. Asset Capitalization of transmission assets in 3QFY13 has been ~Rs. 25.9bn compared to ~Rs. 25.0bn in 2QFY13 and ~Rs. 22.3bn in 3QFY12; it has been ~Rs. 93.5bn for 9MFY13. Capitalization plan for FY13 stands at ~Rs. 170bn. Capital expenditure (capex) in 3QFY13 has been ~Rs. 55.4bn and has been ~Rs. 120bn for 9MFY13. Capex guidance for FY13 stands at >Rs. 200bn with overall 12th Plan capitalization guidance at Rs. 1tn, representing a >80% jump vs the corresponding 11th Plan target. Even if we assume only a ~80% achievement-plan ratio, it gives a robust growth outlook over the long term (FY13-FY17E) ~41% of the revenues booked in the quarter were on the back of provisional tariffs rather than final tariff orders, while in 3QFY12 it was ~14%; we notice that the proportion of revenues booked based on final tariff orders improves by the end of the year (only ~20% of revenues in FY12 was based on provisional tariffs) due to finalization of tariff orders near the end of a year. Hence we expect a similar trend for FY13 with increased revenues in 4QFY13 which will result in net profits of >Rs. 38bn for FY13 vs. ~Rs 32bn in FY12, a 17% yoy growth. Valuation Discussion We tweak our assumption of total capex for FY13 to ~Rs. 170bn (earlier ~Rs. 150bn) incorporating the current quarter’s performance, as compared to management’s guidance of ~Rs. 200bn. Based on these conservative numbers we value the stock at 1.5x our FY15E book value yielding a new target price of Rs. 111/ share (we cut the multiple from 2x earlier due to the recent stock correction on concerns of slowing growth and dependence on more capital). The stock has traded above 1.5x P/BV multiple for 100% of the time in the last 4 years. At CMP of Rs. 105/ share the stock is trading at ~1.4x of our FY15E book value, close to our target price. We like the Company’s improved earnings growth outlook, low operational risks, fixed-RoE business model, availability based tariffs and limited receivable risks. Hence maintain our Add rating with a target price of Rs. 111/ share.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.